Scientists at Imperial College London evaluated the prevalence of standing palpitations and developed guidelines for diagnosing and treating this condition in long-term COVID. Research published BMJ.
Long COVID is when symptoms associated with COVID-19 persist for more than one month after recovery. The symptoms of this condition are varied and can include headaches, fatigue, shortness of breath, and more serious complications. One of these is orthostatic tachycardia, that is, a rapid (more than 30 beats per minute) heartbeat while standing.
Scientists noted that orthostatic tachycardia is caused not by physical activity, but by the transition to a vertical state. Also, patients often experience a feeling of “electric shock”. A diagnosis is made if symptoms persist for more than three months.
Scientists recommend excluding dehydration, sepsis, anemia, hypothyroidism, heart disease and other diseases to diagnose orthostatic tachycardia.
Scientists believe that adequate fluid intake, moderate exercise, adequate sleep, compression stockings and avoidance of aggravating factors (heat, prolonged standing, alcohol and heavy meals) can improve the condition of patients. Scientists also noted the importance of a diet that reduces the risk of bloating. In some cases, the drugs listed in the authors article may be prescribed.
Scientists suggest that orthostatic tachycardia is associated with a malfunction of the autonomic nervous system. It occurs mainly in young people and more often in women. Possible risk factors include a suppressed immune system, obesity, and hypertension.